Orphazyme A/S buy Amped
Start price
25.06.21
/
0%
€6.80
Target price
21.06.22
-
Performance (%)
-88.60%
End price
22.06.22
€0.78
Summary
This prediction ended on 22.06.22 with a price of €0.78. The BUY prediction by Amped for Orphazyme A/S performed very badly with a performance of -88.60%. This prediction was marked as speculative and is excluded from Amped's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Orphazyme A/S | - | - | - | - |
iShares Core DAX® | 2.821% | -1.953% | 15.071% | 11.862% |
iShares Nasdaq 100 | 5.285% | -5.092% | 29.254% | 40.075% |
iShares Nikkei 225® | 3.687% | -4.221% | 14.286% | 6.629% |
iShares S&P 500 | 3.577% | -2.240% | 25.546% | 38.398% |
According to Amped what are the pros and cons of Orphazyme A/S for the foreseeable future?
Pros
EBIT growth >5% per year expected
Capable Management
Known brand
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Good culture
Sustainability is important
Top 10 in its market
Very Future proof/growth oriented business model
Cons
Few uniques
Dependend from some customers or products
Significant cyclical dependencies
Comments by Amped for this prediction
In the thread Orphazyme A/s diskutieren
Buy Orphazyme A/S
In the thread Trading Orphazyme A/s
Die von Amped gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Amped for Orphazyme A/S
Orphazyme A/S
Start price
Target price
Perf. (%)
€0.78
25.06.21
25.06.21
-
21.06.22
21.06.22
-
25.06.21
25.06.21
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Orphazyme A/S
Start price
Target price
Perf. (%)
€6.90
23.06.21
23.06.21
-
21.06.22
21.06.22
-1.45%
25.06.21
25.06.21
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Orphazyme A/S
Start price
Target price
Perf. (%)
€6.30
21.06.21
21.06.21
-
21.06.22
21.06.22
9.52%
23.06.21
23.06.21
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Orphazyme A/S
Start price
Target price
Perf. (%)
€6.55
21.06.21
21.06.21
-
21.06.22
21.06.22
-3.82%
21.06.21
21.06.21
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products